LaPorte v. Gordon

CourtDistrict Court, E.D. Michigan
DecidedMarch 24, 2020
Docket1:20-cv-10089
StatusUnknown

This text of LaPorte v. Gordon (LaPorte v. Gordon) is published on Counsel Stack Legal Research, covering District Court, E.D. Michigan primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
LaPorte v. Gordon, (E.D. Mich. 2020).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN NORTHERN DIVISION

SHANNON LAPORTE, et al., Plaintiffs, v. Case No. 20-10089 Hon. Thomas L. Ludington ROBERT GORDON, DR. Magistrate Patricia T. Morris SANDIP SHAH, DR. SARAH

LYON-CALLO, MARY

KLEYN, AND MARY SEETERLIN, in their official capacities, Defendants.

OPINION AND ORDER DENYING PLAINTIFFS’ MOTION FOR PRELIMINARY INJUNCTION

All 50 states have newborn screening programs for at least 29 health conditions. NIH, How Many Newborns are Screened in the United States?, https://www.nichd.nih.gov/health/topics/ newborn/conditioninfo/infants-screened#f3 (last reviewed 9/1/2017). The screening process is begun by withdrawing a few drops of blood from a baby’s heel 24 to 36 hours after a child’s birth. 50th Anniversary, 1965-2015 Michigan Newborn Screening: A Public Health Success Story, https://www.michigan.gov/documents/mdch/Newborn_Screening_Book_500007_7.pdf. Five or six spots of the blood are maintained on a filter paper card and then sent to the State Newborn Screening Laboratory for testing. Id. The child’s primary medical care provider is informed immediately of any adverse health test result. CDC data show that nationally about 12,500 newborns each year are diagnosed with a condition identified through the newborn screening program. How Many Newborns are Screened in the United States? “Approximately 6.9 million Michigan newborns have been screened with more than 7,200 babies identified with disease and treated early for disabling and life threatening conditions.” 50th Anniversary. MCL § 333.5431 was added to the Michigan public health code in 1978 as part of a comprehensive reform to the code. House Legislative Analysis, HB 4070 (March 21, 1977). The House Fiscal Agency analysis explains that “[p]rovisions are included which would govern the classification of diseases and disabilities, reporting and surveillance, and procedures for the investigation and control of diseases and disabilities.” Id. Initially, the section required a health

professional responsible for assistance in the delivery of the child to test infants for “phenylketonuria and other handicapping conditions” under penalty of a misdemeanor. Public Act 368 of 1978. Over the years the statute was amended, expanding the number of diseases that would be tested by a health professional to more than 50 disorders, adding reporting requirements, and requiring the department to promulgate rules related to the testing. Public Act 300 of 1986; Public Act 14 of 1987; Senate Fiscal Agency, Senate Analysis Section SB 162 (April 14, 1987); Public Act 264 of 1988; Public Act 81 of 1992; Public Act 88 of 1998; Public Act 138 of 1999; Public Act 691 of 2002. In 2000, the legislature added language requiring the department to “develop a

schedule for the retention and disposal of the blood specimens used for the tests after the tests are completed” and allowing the samples to be used for medical research. Public Act 33 of 2000. MCL § 333.5431 currently provides in part, (1) A health professional in charge of the care of a newborn infant or, if none, the health professional in charge at the birth of an infant shall administer or cause to be administered to the infant a test for each of the following: (a) Phenylketonuria. (b) Galactosemia. (c) Hypothyroidism. (d) Maple syrup urine disease. (e) Biotinidase deficiency. (f) Sickle cell anemia. (g) Congenital adrenal hyperplasia. (h) Medium-chain acyl-coenzyme A dehydrogenase deficiency. (i) Other treatable but otherwise disabling conditions as designated by the department. (2) The informed consent requirements of sections 17020 and 17520 do not apply to the tests required under subsection (1). The tests required under subsection (1) shall be administered and reported within a time and under conditions prescribed by the department. The department may require that the tests be performed by the department. The parent or legal representative of a newborn child decides whether all remaining blood samples should be destroyed, only blood samples stored for research should be destroyed, or the blood spots may be stored but not used for research purposes. ECF No. 15-4 at PageID.182. The opt-in and opt-out processes (depending on an individual’s date of birth) are explained on the Michigan Department of Health and Human Services website as well as pamphlets distributed by the department. ECF No. 15-6; 15-8. In short, at birth, a parent or legal guardian decides whether a child’s blood spots may be used for research purposes. See the form below.

Case 1:20-cv-10089-TLL-PTM ECF No. 15-9 filed 02/21/20 PagelD.200 Page 2 of 2 Before you sign this form please read, Your Baby's Blood Spots. It explains in more detail how your a a baby’s blood spots may be used in health research through the Michigan BioTrust for Health. If you a Hoult still have questions, please call the Michigan Department of Health and Human Services. (MDHHS) toll free at 1-866-673-9939. [] Yes, my baby’s blood spots may be used for health research through the BioTrust. By checking this box you understand: ~ Unused blood spots are stored using a code and not your child's name. The spots are stored forever at a secure oO site (Biobank) unless you, or your grown child, change your mind. * Stored blood spots may be used by the state lab to help ensure that newborn screening detects those at risk. wo Stored blood spots may also be used for research approved by MDHHS, Blood spots can only be used for studies + to better understand disease or improve the public's health. ® Many types of laboratory methods are used to study biological factors like DNA or environmental factors like S metals and toxins. ¢ The risk for using your baby’s blood spots in research is that it could be identified. This risk is very low. Many steps are taken to protect privacy. Details that could identify your child or family are removed before your child's — blood spots are given to a researcher. —— ® Most likely you or your child will not benefit from blood spot research. == « Participation is voluntary. You can call MDHHS at any time if you change your mind. There is no penalty orlossof = == benefits for saying no or changing your mind. 8 = □□ No, my baby’s blood spots may not be used for health research. So By checking this box you understand: SS ® Blood spots will be stored forever but not used for research. These stored blood spots may still be used by the E]_—_- state lab to help ensure that newborn screening detects those at risk. = « You must contact MDHHS if you do not want blood spots stored for any reason after newborn screening. Eo @ Parent Signature Date Your choice applies to all blood spots collected for newbom screening. Please visit www.michigan.govw/biotrust for further information including research updates. For questions about your research nights or whom to contact in case of a research-related injury, please call the a MDHHS IRB at 517-241-1928.

-3-

If the parent wants to amend their response and/or have the blood spot destroyed, the following form is used later. Ladase LiZzU-Ly. Uy c Page 4 ulZ ‘RESIDUAL NEWBORN SCREENING BLOGD SPOTDIRECTIVE' Michigan Department of Health and Human Services

Child's Current Name Check Birth Order if Multiple Birth Oi ()3e Clam (54

| am a legal representative* of the child named above. | am asking the Michigan Department of Health and Human Services (MDHHS) to (check one): Destroy all remaining blood spots. | understand that by checking this box, NO blood spots will be available for any future use including medical, identification, or research purposes. Destroy only the portion of blood spots stored for research use. | understand by checking this box, one blood spot will be held by MDHHS. | must direct any potential future use including medical, identification or research purposes.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Jacobson v. Massachusetts
197 U.S. 11 (Supreme Court, 1905)
Prince v. Massachusetts
321 U.S. 158 (Supreme Court, 1944)
Parham v. J. R.
442 U.S. 584 (Supreme Court, 1979)
Harlow v. Fitzgerald
457 U.S. 800 (Supreme Court, 1982)
Mitchell v. Forsyth
472 U.S. 511 (Supreme Court, 1985)
Malley v. Briggs
475 U.S. 335 (Supreme Court, 1986)
Regents of University of California v. Doe
519 U.S. 425 (Supreme Court, 1997)
Pearson v. Callahan
555 U.S. 223 (Supreme Court, 2009)
Michigan State Afl-Cio v. Miller
103 F.3d 1240 (Sixth Circuit, 1997)
Reichle v. Howards
132 S. Ct. 2088 (Supreme Court, 2012)
Flax v. Potts
333 F. Supp. 711 (N.D. Texas, 1970)
Spiering v. Heineman
448 F. Supp. 2d 1129 (D. Nebraska, 2006)
Birchfield v. N. Dakota. William Robert Bernard
579 U.S. 438 (Supreme Court, 2016)
Tara Nikolao v. Nick Lyon
875 F.3d 310 (Sixth Circuit, 2017)
James Maben v. Troy Thelen
887 F.3d 252 (Sixth Circuit, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
LaPorte v. Gordon, Counsel Stack Legal Research, https://law.counselstack.com/opinion/laporte-v-gordon-mied-2020.